*Response Options to Histologic Type
___ Papillary Carcinoma Variant, specify:
___ Classic (conventional)
___ Follicular variant, encapsulated /well demarcated, with tumor capsular invasion
___ Follicular variant, infiltrative
___ Tall cell variant
____Cribriform-morular variant
____Diffuse sclerosing variant
____Other variant (specify)
___Follicular Carcinomas
___Minimally invasive
___Encapsulated angioinvasive
___Widely invasive
___Minimally invasive, oncocytic (Hurthle cell)
___Encapsulated angioinvasive, oncocytic (Hurthle cell)
___Widely invasive, oncocytic (Hurthle cell)
___Minimally invasive, other variant (specify)
___Encapsulated angioinvasive, other variant (specify)
___ Widely invasive, other variant (specify)
___ Poorly differentiated thyroid carcinoma
___ Undifferentiated (anaplastic) carcinoma
____ Focal or minor component without extrathyroidal extension
____ Major component
____ Not otherwise specified
Medullary carcinoma
Other (specify)
Carcinoma, type cannot be determined
**Extrathyroidal extension
Microscopic extrathyroidal extension that is not grossly evident is no longer a criterion for upstaging. The T stages, pT3b, pT4a, pT4b, are now defined by extrathyroidal extension into at least skeletal muscle, which then necessitates review of macroscopic, intraoperative, and radiologic findings. As such, a thorough gross examination and review of the operative and radiologic findings are now essentially required to document the “gross” extrathyroidal extension required to upstage a tumor.
___ Invading only strap muscles
___ Invading subcutaneous soft tissues, larynx, trachea, esophagus or recurrent laryngeal nerve
___ Invading prevertebral fascia or encasing the carotid artery or mediastinal vessels
***Specification of nodal levels (select all that apply)
____Level VI – perithyroidal, pretracheal, paratracheal and prelaryngeal/Delphian (central compartment dissection)
____Level VII (superior mediastinal lymph nodes)
____Level I-V (lateral neck dissection)
____Other (specify)